• Home
  • Welcome
  • CAD & Treatments
  • Donation
  • Resources
  • Webinar Resources
  • Register Web Series
  • Latest News & Articles
  • Members
  • Specialists
  • Media
  • Clinical Trials
  • Our Stories
  • Stay In The Know
  • Medical Advisors
  • Contact Us
  • Privacy & Policies
  • E-Learning Education
  • Observational Study
  • More
    • Home
    • Welcome
    • CAD & Treatments
    • Donation
    • Resources
    • Webinar Resources
    • Register Web Series
    • Latest News & Articles
    • Members
    • Specialists
    • Media
    • Clinical Trials
    • Our Stories
    • Stay In The Know
    • Medical Advisors
    • Contact Us
    • Privacy & Policies
    • E-Learning Education
    • Observational Study
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Welcome
  • CAD & Treatments
  • Donation
  • Resources
  • Webinar Resources
  • Register Web Series
  • Latest News & Articles
  • Members
  • Specialists
  • Media
  • Clinical Trials
  • Our Stories
  • Stay In The Know
  • Medical Advisors
  • Contact Us
  • Privacy & Policies
  • E-Learning Education
  • Observational Study

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Latest NEWS & articles

Cision PR Newswire

RareDisease Advisor

RareDisease Advisor

 Hummingbird Bioscience to Present Preclinical Proof of Concept for Potentially First-In-Class Antibody Targeting Autoimmune Diseases.

Learn more

RareDisease Advisor

RareDisease Advisor

RareDisease Advisor

Understanding the Burden of Cold Agglutinin Disease.

Learn more

JMCP Journal

Cold Agglutinin Disease News

Cold Agglutinin Disease News

An observational analysis of disease burden in patients with cold agglutinin disease: Results from a large US electronic health record database.

Learn more

Cold Agglutinin Disease News

Cold Agglutinin Disease News

Cold Agglutinin Disease News

Welcome to ‘Exploring the Jungle,’ a trek into the unknowns of CAD.

Learn more

MedScape Article

Cision PR Newswire

Cision PR Newswire

  Cold Agglutinin Disease Clinical Presentation.

Learn more

Cision PR Newswire

Cision PR Newswire

Cision PR Newswire

Cold Agglutinin Disease Market to Exhibit Massive Growth at a CAGR of 28% in the 7MM for the Study Period of 2019-32 | DelveInsight.

Learn more

JMIR Publications

Cision PR Newswire

JMIR Publications

The Burden of Cold Agglutinin Disease on Patients’ Daily Life: Web-Based Cross-sectional Survey of 50 American Patients.

Learn more

What is CAD

Research & Practice

What is CAD

 UNDERSTANDING HOW COLD AGGLUTININ DISEASE (CAD) OCCURS.

Learn more

Case Report

Research & Practice

What is CAD

Cold agglutinin-induced hemolytic anemia during room temperature fluid resuscitation: a case report.

Learn more

Research & Practice

Research & Practice

Research & Practice

Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis.

Learn more

National Library of Medicine

National Library of Medicine

National Library of Medicine

     Iron overload occurs when there are excess stores of iron in the body. 

Learn more

Haematologica

National Library of Medicine

National Library of Medicine

    IgM monoclonal gammopathies of clinical significance: diagnosis and management.

Learn more

Practice Update

National Library of Medicine

Practice Update

  Sustained Hematologic Remission After Discontinuation of Sutimlimab Treatment in Patients With CAD

Learn more

National Library of Medicine

National Library of Medicine

National Library of Medicine

    Effects of Cold Agglutinin on the Accuracy of Complete Blood Count Results and Optimal Sample Pretreatment Protocols for Eliminating Such Effects

Learn more

BioChemia Medica

National Library of Medicine

National Library of Medicine

   70-year old female patient with mismatch between hematocrit and hemoglobin values: the effects of cold agglutinin on complete blood count

Learn more

ASH Clinical News

National Library of Medicine

ASH Clinical News

 Sigbjørn Berentsen, MD, PhD, discusses the diagnosis and management of cold agglutinin disease, a rare subtype of autoimmune hemolytic anemia. 

Learn more

FDA | Enjaymo®

FDA | Enjaymo®

FDA | Enjaymo®

   The FDA has approved expanded use of Enjaymo to US patients who are not transfusion dependent.

Learn more

Sanofi Genezyme

FDA | Enjaymo®

FDA | Enjaymo®

  Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease

Learn more

Sanofi Genezyme

FDA | Enjaymo®

Sanofi Genezyme

 Food and Drug Administration (FDA) approves Enjaymo (sutimlimab-jome)

Learn more

Larry Luxner

Webinar Series & Presentation

Rituxan & Treatments

Article: CAD Foundation Strives to Increase Knowledge of this disease.

Learn more

Rituxan & Treatments

Webinar Series & Presentation

Rituxan & Treatments

 CAD Foundation Summit Series - March 23/2021

Learn more

Webinar Series & Presentation

Webinar Series & Presentation

Webinar Series & Presentation

February 23, 2021 CAD/COVID & Dr. Furman's Webinar January 19, 2021 

Learn more

Insights and Answers

Info For Medical Professionals

Webinar Series & Presentation

 International Society for Pharmacoeconomics and Outcomes Research 

Learn more

Info For Medical Professionals

Info For Medical Professionals

Info For Medical Professionals

Medical Advisors who have endorsed CADF 

Feb 19, 2021

Learn more

Corona Virus & CAD

Info For Medical Professionals

Info For Medical Professionals

News Release, December, 07 2020

Learn more

FDA Complete Response

Dr. Catherine Elizabeth Connolly

Complete the Questionaire

This is not a roadblock; it's only a detour. 

Learn more

Complete the Questionaire

Dr. Catherine Elizabeth Connolly

Complete the Questionaire

Survey on the experience of patients living with cold agglutinin disease

Learn more

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

My Dad's diagnosis of CAD. Part 2: Slowing Down  

Learn more

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

Understanding through experience, My Dad’s diagnosis of CAD Part 1.  

Learn more

Sanofi's Biologics

Dr. Catherine Elizabeth Connolly

Sanofi's Biologics

FDA grants priority review of Sutimlimab. Potenial first approved treatment.

Learn more

Impact - Covid-19

Dr. Catherine Elizabeth Connolly

Sanofi's Biologics

In support of rare disease patients that are impacted.

Learn more

NEWS lETTERS

Dec Edition #3

Sept Edition #2

Sept Edition #2

Welcome to CADdy News Our 3nd edition newsletter 

December 2020 Edition

Sept Edition #2

Sept Edition #2

Sept Edition #2

Welcome to CADdy News Our 2nd edition newsletter 

September 2020 Edition

July Edition #1

Sept Edition #2

July Edition #1

Welcome to CADdy News Our 1st edition newsletter

July 2020 Edition

Copyright © 2022 Cold Agglutinin Disease Foundation - All Rights Reserved.

Privacy & Policies

Contact Us: info@cadfadvocacy.org

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept